Pfizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending XELJANZ (tofacitinib citrate) 5 mg twice Read More
Pfizer gets positive CHMP Opinion in Europe for XELJANZ
